Literature DB >> 28051115

Therapy: Once-weekly growth hormone.

Claire Greenhill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28051115     DOI： 10.1038/nrendo.2016.220

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.

Authors:  Christian J Strasburger; Peter Vanuga; Juraj Payer; Marija Pfeifer; Vera Popovic; László Bajnok; Miklós Góth; Veˇra Olšovská; L'udmila Trejbalová; Janos Vadasz; Eyal Fima; Ronit Koren; Leanne Amitzi; Martin Bidlingmaier; Oren Hershkovitz; Gili Hart; Beverly M K Biller
Journal:  Eur J Endocrinol       Date:  2016-12-08       Impact factor: 6.664
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.